Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger
In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a rapidly emerging virus causing the coronavirus disease 2019 (COVID-19) pandemic, had no known effective prophylaxis and no widely available proven effective antiviral treatment. Hydroxychloroquine/Chloroquine was identified as...
Saved in:
Main Author: | Kabore Y. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/90021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
by: Nicholas J. White, et al.
Published: (2020) -
Effect of hydroxychloroquine in hospitalized patients with Covid-19
by: Peter Horby, et al.
Published: (2020) -
Chloroquine and hydroxychloroquine: Efficacy in the treatment of the COVID-19
by: Ho, Tzu-Chuan, et al.
Published: (2022) -
History of Changes in the Protocol of Clinical Trial of Zinc Supplementation in Treatment of COVID-19 by Hydroxychloroquine
by: Sornsil D.
Published: (2023) -
Does hydroxychloroquine still have any role in the COVID-19 pandemic?
by: William H.K. Schilling, et al.
Published: (2022)